Presenting author
Michael E. Thase
4 presentations
Designing the next generation of studies of psychedelics for difficult to treat depression
A short journey through a 50 years of progress in the treatment of depression
W22. GH001 efficacy is independent of prior antidepressant treatment failures in treatment-resistant depression: A post hoc analysis of a phase 2b randomized controlled trial
W23. Examining the impact of patient-centered approaches on the assessment and management of cognitive impairment in major depressive disorder